PROCEPT BioRobotics Corp(PRCT)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
PRCT has no upcoming report date in the calendar yet. It last reported on Nov 4, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±11.0%).
Did the stock rise after good news?
The next-day move after each of its last 6 EPS beats and 4 misses.
In plain words: it beat expectations 6 times, but the stock still fell 4 of those 6 times.
- Nov '26Missed▼ -6.4%
- Aug '26Missed▲ +5.8%
- Feb '26Missed▼ -15.1%
- Nov '25Beat▼ -9.7%
- Aug '25Beat▼ -13.4%
- Apr '25Beat▼ -5.6%
- Oct '24Beat▲ +32.3%
- Aug '24Beat▼ -7.5%
- May '24Beat▲ +14.4%
- Feb '24Missed▼ -2.7%
Clear beats and misses with a known reaction only. What counts as a beat
Why did PRCT fall after beating earnings?
5 of PRCT's last 10 reactions went against the EPS result. What stands out in each:
PRCT beat EPS estimates in 6 quarters, and the stock still closed lower the next day 4 times. In 1 of the 4 where we have price data, the stock had already run up before the report.
- Nov 4, 2025EPS beat +9.5%stock -9.7% next day
- It opened 6.5% lower as soon as trading resumed.
- Aug 6, 2025EPS beat +14.6%stock -13.4% next day
- It opened 8.1% lower as soon as trading resumed.
- Apr 24, 2025EPS beat +8.2%stock -5.6% next day
- It had risen 5.3% in the final week before the report, so good news may already have been priced in.
- It opened 2.3% higher, but sellers took over and it closed -5.6%.
- Aug 1, 2024EPS beat +3.8%stock -7.5% next day
- It opened 4.9% lower as soon as trading resumed.
Rose despite an EPS miss (1 of 4)
- Aug 4, 2026EPS missed -4.4%stock +5.8% next day
- It had already fallen 13.1% in the 20 trading sessions before the report, so weak results may have been expected.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was PRCT's earnings move already priced in?
PRCT's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does PRCT hold its opening gap after earnings?
PRCT's opening move after each report and where it closed that day.
In 11 reports PRCT opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 11 times (27%), and fully reversed 2 times. Gaps up faded 1 of 5; gaps down recovered 2 of 6.
- Aug 4, 2026ReversedOpened -4.5%, closed +5.8%
- Apr 29, 2026HeldOpened +10.9%, closed +10.7%
- Feb 25, 2026HeldOpened -29.6%, closed -15.1%
- Nov 4, 2025HeldOpened -6.5%, closed -9.7%
- Aug 6, 2025HeldOpened -8.1%, closed -13.4%
- Apr 24, 2025ReversedOpened +2.3%, closed -5.6%
- Feb 25, 2025HeldOpened +4.5%, closed +8.6%
- Oct 28, 2024HeldOpened +27.9%, closed +32.3%
What the history says
- It fell after 4 of its 6 EPS beats (67%): beating estimates has not been enough on its own.
PRCT earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | Revenue surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | After close | -$0.39 | -$0.46 | -17.9% | -6.0% | -6.42% | — |
| Aug 4, 2026 | After close | -$0.45 | -$0.47 | -4.4% | — | +5.80% | +11.65% |
| Apr 29, 2026 | After close | -$0.56 | -$0.56 | 0.0% | — | +10.73% | +14.37% |
| Feb 25, 2026 | After close | -$0.32 | -$0.53 | -65.6% | — | -15.12% | -6.97% |
| Nov 4, 2025 | After close | -$0.42 | -$0.38 | +9.5% | — | -9.74% | -8.85% |
| Aug 6, 2025 | After close | -$0.41 | -$0.35 | +14.6% | — | -13.35% | -15.15% |
| Apr 24, 2025 | Before open | -$0.49 | -$0.45 | +8.2% | — | -5.64% | -2.76% |
| Feb 25, 2025 | After close | -$0.35 | -$0.35 | 0.0% | — | +8.61% | +2.60% |
| Oct 28, 2024 | Before open | -$0.49 | -$0.40 | +18.4% | — | +32.33% | +35.28% |
| Aug 1, 2024 | After close | -$0.52 | -$0.50 | +3.8% | — | -7.45% | -2.29% |
| May 1, 2024 | Before open | -$0.56 | -$0.51 | +8.9% | — | +14.40% | +21.39% |
| Feb 27, 2024 | After close | -$0.45 | -$0.54 | -20.0% | — | -2.68% | -3.33% |
PRCT Earnings FAQ
Answers computed from PROCEPT BioRobotics Corp's reported history
PRCT has no upcoming report date in the calendar yet. It last reported on Nov 4, 2026; companies usually report every three months.
Over the last 12 quarters with a usable EPS surprise, PRCT beat the consensus estimate 6 times (50%), missed 4 and landed in line 2. It has missed estimates in each of the last 2 counted quarters.
Across its last 12 quarters with a measured reaction, PRCT moved an average of ±11.0% in the first session after reporting. It closed higher 42% of the time; the largest gain was 32.3% and the largest drop -15.1%.
PRCT fell in the first session after 4 of its last 6 EPS beats (67%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 1 of the 4 of those falls where price data is available, the stock had already risen before the report.
Across its last 12 quarters with price data, PRCT moved an average of -5.0% in the 20 trading sessions before reporting and was higher in 33% of them. After a run-up of 3% or more (3 quarters), it fell the next day 67% of the time, averaging +1.8%. After a drop of 3% or more (7 quarters), it rose the next day 57% of the time, averaging +3.3%. This describes past reports; it is not a forecast.
In 11 reports PRCT opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 11 times (27%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · PRCT: 12 reported quarters, latest Nov 4, 2026. Information only, not investment advice.
Looking for more on PRCT?
Price charts, forecast, fundamentals and risk pages for PRCT are not on Tickzen yet. You can run a full stock analysis now.
Run the PRCT Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun